Enhanced Marginal Sensitivity Model and Bounds
Yi Zhang, Wenfu Xu, Zhiqiang Tan
TL;DR
The paper develops the Enhanced Marginal Sensitivity Model (eMSM), augmenting the traditional Marginal Sensitivity Model with an outcome-based sensitivity constraint to tighten bounds under unmeasured confounding. It derives sharp population bounds for the mean potential outcome $\mu^1$ under eMSM, provides conditions and a practical specification for parameter choices, and establishes doubly robust, calibratable estimators and confidence intervals for these bounds. By connecting eMSM to DV methods, the authors show how DV bounds can be viewed as unions of eMSMs with compatible parameters, and they derive sharp DV bounds via this framework. The approach is demonstrated through two real-data applications (RHC and NHANES), where eMSM yields notably narrower sensitivity intervals than MSM and yields robust conclusions under plausible levels of hidden confounding, illustrating its practical value for causal inference in observational studies.
Abstract
Sensitivity analysis is important to assess the impact of unmeasured confounding in causal inference from observational studies. The marginal sensitivity model (MSM) provides a useful approach in quantifying the influence of unmeasured confounders on treatment assignment and leading to tractable sharp bounds of common causal parameters. In this paper, to tighten MSM sharp bounds, we propose the enhanced MSM (eMSM) by incorporating another sensitivity constraint that quantifies the influence of unmeasured confounders on outcomes. We derive sharp population bounds of expected potential outcomes under eMSM, which are always narrower than the MSM sharp bounds in a simple and interpretable way. We further discuss desirable specifications of sensitivity parameters related to the outcome sensitivity constraint, and obtain both doubly robust point estimation and confidence intervals for the eMSM population bounds. The effectiveness of eMSM is also demonstrated numerically through two real-data applications. Our development represents, for the first time, a satisfactory extension of MSM to exploit both treatment and outcome sensitivity constraints on unmeasured confounding.
